Akorn

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Akorn ( AKRX) manufactures and markets a range of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. This stock is trading up 1.5% at $10.82 in recent trading after hitting a 52-week high of $11.14 earlier in the day.

Today's Range: $10.73-$11.14

52-Week Range: $4.87-$11.14

Volume: 470,000

Three-Month Average Volume: 1.2 million

Akorn has a market cap of $1.03 billion and an enterprise value of $982 million. The stock trades at a trailing price-to-earnings of 19.1 and a forward price-to-earnings of 29.27. Its estimated growth rate for this year is 72.2%, and for next year it's pegged at 19.4%. The current short interest as a percentage of the float for Akorn is notable at 8%.

From a technical standpoint, AKRX is quickly approaching a big breakout trade if the stock can manage to clear some near-term overhead resistance at $11.14.

Market players should now look for a sustained high-volume move and close above $11.14. Look for volume on that potential breakout that hits near or above 1.2 million shares. If we get that action, then this stock should continue to trend significantly higher.

If you liked this article you might like

Cramer's 6 Stocks in 60 Seconds: GOGO AGN CTAS BYI DECK HCA (Update 1)

Bally Technology Shuffles SHFL in $1.3B Deal

Cramer's 'Mad Money' Recap: Next Week's Game Plan

Two Speculative Long-Side Trades

Two Speculative Long-Side Trades

Stock Futures Gain Momentum